Dopamine D3/D2 Receptor Partial Agonists For The Treatment Of Neuropsychiatric Disorders
European Patent
23800603.5
Filed on 2025-04-03
23800603.5
Filed on 2025-04-03
DOPAMINE D3/D2 RECEPTOR PARTIAL AGONISTS FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS
US Application 19/116,951
Filed on 2025-03-28
Filed on 2025-03-28
Dopamine D3/D2 Receptor Partial Agonists For The Treatment Of Neuropsychiatric Disorders
Australia
2023353560
Filed on 2025-03-17
2023353560
Filed on 2025-03-17
Dopamine D3/D2 Receptor Partial Agonists For The Treatment Of Neuropsychiatric Disorders
Canada
3268476
Filed on 2025-03-21
3268476
Filed on 2025-03-21
DEVELOPMENT OF BROAD-SPECTRUM ANTI-OPIOID VACCINES
Patent Cooperation Treaty
PCT/US2024/057069
Filed on 2024-11-22
PCT/US2024/057069
Filed on 2024-11-22
SELECTIVE OPIOID RECEPTOR AGONISTS AND ANTAGONISTS
European Patent
23758151.7
Filed on 2025-02-26
23758151.7
Filed on 2025-02-26
SELECTIVE OPIOID RECEPTOR AGONISTS AND ANTAGONISTS
US Application 19/099,189
Filed on 2025-01-28
Filed on 2025-01-28
Development of bacteriophage mQb-6-AmHap vaccine for the treatment of opioid use disorder
US Application 63/617,555
Filed on 2024-01-04
Filed on 2024-01-04
DEVELOPMENT OF ANTI-OPIOID VACCINES
US Application 63/601,913
Filed on 2023-11-22
Filed on 2023-11-22